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INTRODUCTION
One of the major mechanisms of ionizing radiation (IR)-induced cell death is the generation
of reactive oxygen species (ROS) that attack cellular DNA (McBride et al, 2004; Moller and
Loft, 2004; Moulder, 2002). For cancer patients receiving radiotherapy (RT), IR-induced
normal tissue damage is a dose-limiting factor (Lee et al, 2003; Moulder, 2002). This obstacle
to cancer treatment, along with the increasing threat of bioterrorism, creates an urgent need for
the identification of effective radiation countermeasures (Moulder, 2002; Stone et al, 2004).
Ginseng is one of the most frequently purchased herbs in the United States. The two most
commonly used species, Panax ginseng C.A. Meyer (Asian ginseng) and Panax
quinquefolius L. (North American ginseng), have drawn widespread attention for their
multifold medicinal bioactivities (anti-diabetic, anti-carcinogenic, anti-pyretic, analgesic, anti-
aging, anti-stress, and anti-fatigue effects), and for their promotion of DNA, RNA, and protein
synthesis (Attele et al., 1999; Kitts et al, 2000; Lee et al., 2005). Moreover, because of its
effective antioxidant capacity, studies on the radioprotective effects of Asian ginseng have
engendered interest, but the research has primarily been done in animal models (Arora et al.,
2005; Kim et al; 2007; Han et al., 2005; Lee et al., 2006; Lee et al., 2005). We recently
demonstrated in human peripheral blood lymphocytes (PBL) the ability of a crude water extract
of Asian ginseng, applied at 24 h before radiation exposure to prevent 137Cs-induced
micronuclei (MN) formation ex vivo in a dose-dependent manner (Lee et al., 2004a). These
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findings have led us to more thoroughly investigate the potential of ginseng as a safe and natural
radioprotector. Because the bioactive components of ginseng and its radioprotective potential,
are linked with its ginsenoside content (Attele et al., 1999; Gillis., 1997; Kitts et al., 2000; Lee
et al., 2005), it has become apparent that a more standardized source of ginseng than we used
in our original study (Lee et al., 2004a) is essential to avoid batch-to-batch variations. Thus,
we have switched our focus from the use of Asian ginseng to a standardized formulation of
North American ginseng extract (NAGE) that contains the highest ginsenoside concentration
(11.7%) currently available on the market (Hall et al., 2001).
Micronucleus (MN) formation is one of the standardized biomarkers for assessing IR-induced
damage both in vivo and ex vivo (Fenech, 2005). To evaluate the radioprotective potential of
NAGE, objectives of this study were to (1) evaluate whether the application of NAGE to culture
medium at 0 h and even 90 min after radiation exposure would reduce the MN yields in human
PBL ex vivo; and (2) assess whether this MN reduction, if present, is NAGE concentration-
dependent. In addition, WR-1065, a prodrug that becomes active after dephosphorylation, is
the biologically active aminothiol form of amifostine (Hoffman et al., 2001; McBride et al.,
2004). Since amifostine (WR-2721) is currently the “gold standard” of radioprotectors, we
compared our results with those from comparable experiments, using optimal concentrations
of WR-1065, as in our previous study (Lee et al., 2004b), to further verify the radioprotective
potential of NAGE. We believe that the information generated from this study will provide a
foundation for clinical trials assessing the potential of standardized dietary NAGE supplements
as an effective natural radiation countermeasure, either before or after radiation exposure; it
would thus be a significant contribution to public health, national defense and environmental
remediation, not only for cancer patients undergoing RT, but also for victims of accidental or
terrorist exposure.
MATERIALS AND METHODS
Subjects
This study was approved by our University Medical Center Institutional Review Board.
Healthy individuals (6M/6F) with a mean age of 46.4 ± 15.7 years (mean ± SEM) without
known history of exposure to mutagens were included in this study; all of them signed informed
consent before enrollment. No subject was currently taking any other pharmacologic agent,
including medications, vitamins, or dietary supplements.
NAGE preparation and ginsenosides
We purchased the standardized NAGE powder (Lot #TKGS-010406) from the Canadian
Phytopharmaceuticals Corporation (Richmond, BC, Canada). Using high-performance liquid
chromatography, the vendor characterized the major ginsenosides in this NAGE powder as
follows: Rb1 (5.1%), Rb2 (0.99%), Rc (1.88%), Rd (1.23%), Re (2.14%), and Rg1 (0.36%),
with a total ginsenoside content (w/w) of 11.7%. To ensure stability, we stored the NAGE in
a cool, dry, dark location over the course of the study. Before experimentation, we filtered a
known concentration of a solution of freshly prepared lyophilized NAGE powder in RPMI
1640 culture medium through a 0.2 μm disc (Millipore, MA) under sterile conditions, to be
used as the stock solution.
WR-1065 preparation
Dr. Robert J. Schultz (Drug Synthesis and Chemistry Branch, NIH-NCI, Bethesda, MD, USA)
kindly provided WR-1065. Immediately before use, we prepared a stock solution of WR-1065
in RPMI 1640 culture medium and filtered it through a 0.2 μm disc (Millipore, MA).
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Cytokinesis-block micronucleus (CBMN) assay
Fresh peripheral blood samples were collected from each subject into Vacutainer Cell
Preparation Tubes (Becton-Dickson, NJ, USA). Mononuclear cells were isolated by density
gradient centrifugation at 1800 g for 20 min, washed, and counted on a hemacytometer. Trypan
blue exclusion showed their viability to be > 95%. The purity of mononuclear cells was > 95%
as determined by Hema-3 staining (Fisher Scientific, NC, USA). The cells were incubated in
polystyrene culture tubes containing RPMI 1640 culture medium (Sigma Chemical, MO,
USA), supplemented with 10% fetal calf serum, L-glutamine, and penicillin and streptomycin.
The final volume of each culture was 1 ml. Duplicate cultures were set up for each experimental
point within 60 min after venipuncture. Phytohemagglutinin (PHA, M Form, Invitrogen Corp.
CA, USA) was added to each culture (1.5%, v/v) immediately after ex vivo radiation exposure.
Cytochalasin B (Sigma Chemical, MO, USA) was applied at 44 h after the PHA stimulation,
with a final concentration of 4 μg ml-1. All cultures were maintained in a humidified atmosphere
of 5% CO2 at 37°C, and were terminated after another 24 h. Slides were prepared according
to Fenech et al (1985) and stained with Hema-3 (Fisher Scientific, NC, USA).
Application of NAGE
We carried out a series of preliminary studies to ascertain the optimum radioprotective dose
of NAGE; these studies showed that treatment of PBL with NAGE at 500-750 ug ml-1 at 0 h
caused a significant reduction in 137Cs-induced MN yield. Therefore, to determine a dose-
response radioprotective effect of NAGE, in each experiment we applied five different NAGE
concentrations (50, 250, 500, 750, and 1000 μg ml-1) to mononuclear cell cultures (2-3 × 105
cells ml-1) in RPMI 1640 at 0 h and at 90 min post irradiation for the CBMN assay.
Application of WR-1065
For each experimental condition, we serially diluted the stock solution of WR-1065 with the
culture medium to the desired final concentrations (1 mM or 3 mM). We chose these two
different concentrations of WR-1065 for quantification of their radioprotective effect on PBL
based on our previous study (Lee et al., 2004b). We then applied WR-1065 (1 mM or 3 mM)
to mononuclear cell cultures (2-3 × 105 cells ml-1) at 0 h and 90 min post irradiation. After the
10-minute treatment with WR-1065, cell cultures were centrifuged, washed with phosphate-
buffered saline (PBS) to remove the WR-1065, and resuspended in the RPMI 1640 culture
medium for the completion of the CBMN assay.
Ex vivo irradiation
The human G0 PBL in the presence or absence of NAGE and WR-1065 were exposed ex
vivo to 137Cs γ- rays (Gamma Cell 40, Radiation Machinery, Ontario, Canada) with 1 or 2 Gy
(0.6 Gy/min) at room temperature (22° C).
Microscopy
Slides were coded and randomized to guarantee anonymity, and only one researcher (WW)
performed the microscopy to ensure consistency of scoring. Under 400X magnification, in
continuous fields from two slides prepared for each experimental check point, a minimum of
1000 consecutive nucleated PBL were evaluated for the numbers of lymphocytes that had
proceeded through one or more cell cycles, including mononucleated, binucleated (with or
without MN formation), and cells with more than two nuclei (>2 nuclei). Further, for the
determination of MN yield at each experimental checkpoint, a minimum of 1000 binucleated
(BN) cells were scored when possible. The quantification of MN yield was restricted to BN
cells with distinct intact cytoplasm, including those with nuclear bridges. MN with smooth
edges touching the main nucleus and those with clearly defined overlap were also included in
the count. The distribution of MN number in each BN cell was recorded as well. The MN yield
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was determined as MN yield = (total number of MN in BN cells/total number of scored BN
cells) × 1000. Percentage reduction of MN was determined as the ratio of 137Cs - induced MN
yield in varying concentrations of NAGE or WR-1065 to the MN yield with radiation alone.
The micronucleated (MN+) BN index was calculated as MN+BN = (Total number of
micronucleated BN cells/total number of BN cells scored) × 100. The proliferation index (PI)
of PBL for each experimental point was determined as PI = [(1 × number of mononucleated
cells) + (2 × number of BN cells) + (3 × number of cells with >2 nuclei)] / total number of
scored cells (Littlefield et al., 1993).
Statistical analyses
We used the software package SPSS (2001) for the data analysis; all data were blinded as to
subject status. Measurements were summarized as the mean ± SEM (standard error of the
mean). Statistical methods consisted of repeated measurements, with analysis of variance and
linear regression, both using a mixed models approach with random intercepts. At different
time points (0 h or 90 min post irradiation), linear contrasts were used to examine the effect of
NAGE (0 - 1000 μg ml-1) and WR-1065 (1 mM and 3 mM) on the 0 - 2 Gy radiation-induced
MN yield in PBL. To evaluate the MN yield distributions relative to the Poisson distribution,
the variance-to-mean ratio (δ2/ μ) and μ-parameter were defined by a goodness of fit test
(Savage, 1970). Radiation doses, time points, concentrations of NAGE and WR-1065, and MN
yields in different individuals were completely cross-classified in a factorial fashion. The effect
of radiation on MN yield and PI of PBL with and without the presence of NAGE and WR-1065,
and the interactions between radiation doses and concentrations of NAGE and WR-1065 were
evaluated separately.
RESULTS AND DISCUSSION
After a mutagenic attack, the micronuclei (MN) in interphase cells are derived from the mitotic
loss of acentric fragments or from lagging chromosomes that are not incorporated into the
daughter nuclei (Fenech and Morley, 1985). The degree of MN formation represents a
particularly interesting endpoint covering both clastogenicity and aneugenicity induced by
mutagens in mammalian cells (Decordier and Kirsch-Volders, 2006). Because of its reliability
and technical ease, and because of the direct correlation between MN formation and genomic
damage, the cytokinesis-block MN (CBMN) assay of peripheral blood lymphocytes (PBL) is
a sensitive measure of in vivo cytogenetic damage in patients receiving partial-body
radiotherapy (Catena et al., 1996; Lee et al., 2003). Therefore, we employed the CBMN assay
of PBL in this study. The effects of NAGE and WR-1065 applied at different time points on
MN yield (mean ± SEM) and MN+BN index in irradiated and non-irradiated PBL are
summarized in Tables 1 - 4. We found that in the absence of NAGE or WR-1065, the mean
(±SEM) baseline MN yield of PBL obtained from 12 healthy individuals at 0 Gy ranged from
14.4 ± 1.5 to 15.9 ± 1.5 per 1000 BN cells (P>0.05). At 0 h, with the increment of NAGE
concentrations in PBL culture medium, a trend of decline from the mean baseline MN yield
appeared, with a reduction rate of up to 31.6% when the applied concentration of NAGE was
750 μg ml-1, compared to that in the absence of NAGE. A comparable trend also appeared for
in the MN+BN yield, but regression analysis indicated these trends were not statistically
significant (P >0.05). At 0 Gy, the different concentrations of NAGE and WR-1065 applied
at various time points did not affect the MN+BN index in PBL (P >0.05, Tables 3 - 4). In
contrast, radiation alone at 1 Gy and 2 Gy linearly increased the MN yield to 128.0 ± 7.1 (Table
2) and 247.8 ± 10.3 (Table 1) per 1000 BN cells, respectively. However, at 0 h or even at 90
min post irradiation (Figures 1 - 2), application of NAGE to PBL culture medium induced a
strong decline in MN yields per 1000 BN cells as NAGE concentration increased (P < 0.0001).
Compared with radiation alone at 1 Gy, NAGE reduced the MN yield by a minimum of 22.5%
when the lowest concentration (50 ug ml-1) was applied at 0 h, while the maximum reduction
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of MN yield was 53.8% when 750 ug ml-1 of NAGE was applied at 90 min post irradiation.
After 2 Gy irradiation , the minimum reduction of MN yield was 19% when the lowest
concentration of NAGE (50 ug ml-1) was applied at 90 min post irradiation, while the maximum
reduction of MN yield rose to 48.8% when 750 μg ml-1 of NAGE was applied at 0 h. The best
fit for the relationship between increasing NAGE concentrations and 137Cs-induced MN yield
in BN lymphocytes was a simple linear regression model (Table 5): Y = Intercept + (Slope)
D (P <0.0001), where Y is the MN yield per 1000 BN cells and D is the NAGE concentration
(50-1000 ug ml-1). There was evidence of a bending upward, or positive quadratic component,
at 0 h (Fig. 1). However, the quadratic trend was shallow and could not be reliably estimated.
A similar trend was also found in MN+BN index response to NAGE treatment afterirradiation
(Table 3 - 4).
We previously found that when compared to radiation alone, a 24-hr incubation with self-
prepared Asian ginseng crude water extract (500 μg ml-1) reduced MN yields by 22% after 1
Gy exposure and 22.5% after 2 Gy exposure in PBL cultures obtained from four healthy
individuals (Lee et al., 2004a). In the present study of PBL obtained from 12 healthy
individuals, application of 500 μg ml-1 of standardized NAGE at 0 h reduced MN yields by
45.3% after 1 Gy and 45.1% after 2 Gy exposure (Table 1), compared to MN yields from
irradiated, unprotected PBL. Even at 90 min post irradiation, 500 μg ml-1 of NAGE reduced
MN yields in PBL by 37.7% and 28.6% after 1 Gy and 2 Gy irradiation respectively, compared
to MN yields after radiation alone (Table 2). In both studies, the decline in radiation-induced
MN yield in PBL was inversely correlated with ginseng concentration in a linear fashion,
although the ginsenoside content in the previous study was unknown. As mentioned above,
the concentrations of total ginsenosides (w/w) in Asian ginseng root usually falls in the range
of 1.5% - 7% (Liu and Xiao., 1992), and 4% is the concentration of the most widely used
standardized Asian ginseng extract G115 (Pharmaton, Switzerland). In contrast, the NAGE
used in the current study was standardized to a total of 11.7% (w/w) ginsenoside content, the
highest currently available (Liu and Xiao., 1992); thus, NAGE showed a much more
pronounced radioprotective effect than did Asian ginseng when evaluated by the MN yield in
human PBL (Lee et al., 2004a).
At both 0 h and 90 min post irradiation, WR-1065 treatment resulted in a significant reduction
of MN yields per 1000 BN cells with a linear-quadratic trend as WR-1065 concentration
increased (Table 5, P <0.004). The best fit regression equation of the relationship between the
concentration of WR-1065 and 137Cs-induced MN yield in BN lymphocytes was: Y = Intercept
+ (Slope)D + (Curvature)D2 (P<0.004), where Y is the MN yield per 1000 BN cells and D is
the WR-1065 concentration (1 mM or 3 mM). Compared with radiation alone at 1 Gy, WR-1065
reduced the MN yield in PBL by a minimum of 47% when 1 mM was applied at 90 min post
irradiation (Table 2), while the maximum reduction in MN yield was 61.2% when 3 mM was
applied at 0 h (Table 1). After 2 Gy irradiation, WR-1065 reduced the MN yield in PBL by a
minimum of 36.2% when a concentration of 1 mM was applied at 0 h, and the maximum
reduction rose to 54.4% when a concentration of 3 mM was applied at 0 h (Table 1). The trend
in MN+BN yield response to WR-1065 treatment at different time points after irradiation was
also similar to that of MN decline (Tables 3-4).
Based upon the goodness of fit tests for the Poisson distribution, the MN yield data obtained
from the different experimental conditions were significantly overdispersed. Overdispersion
indicates a disproportionally increased incidence of PBL carrying MN as described by a
negative binomial distribution. The MN distributions in this study did not follow a Poisson
distribution but deviated from it (data not shown); our results agree well with those reported
in the literature (Catena et al., 1996). At no point in time did application of NAGE and WR-1065
to PBL culture medium show any significant effect on the PI of PBL either before or after the
ex vivo 137Cs irradiation (data not shown).
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The data we generated in this study provide strong evidence that standardized NAGE protected
against 137Cs-induced MN formation in human PBL ex vivo in a concentration-dependent
manner. Across the applied 1-2 Gy radiation dose range, the yields of MN in PBL treated with
NAGE were consistently lower than those without NAGE treatment at 0 h and even at 90 min
post irradiation. This highly significant decline in MN yield correlated in a linear fashion with
NAGE concentration (Table 5). Tables 1 - 2 show that the extent to which NAGE administered
at different points in time reduced the MN yield induced in PBL by 1 Gy or 2 Gy irradiation
ranged from 22.5% - 53.8% and 19% - 48.8%, respectively. Since unrepaired or misrepaired
DNA damage is responsible for MN formation in human PBL (Fenech, 2005), these findings
indicate the radioprotective potential of NAGE.
Because radioprotective agents are known to be most effective when applied before IR
exposure, and must be present in the system at the time of irradiation (Coleman et al., 2004;
Kumar et al., 2003; Moulder, 2002); thus, the time of administration of a radioprotector is
critically important. In our previous preliminary report (Lee et al., 2004a), we found that the
administration of Asian ginseng crude water extract to human PBL ex vivo 24 h before radiation
exposure resulted in a significant linear decline of MN yields as ginseng concentration
increased. In the current study, we further demonstrate for the first time that the application of
standardized NAGE (50 - 1000 μg ml-1) to PBL cultures obtained from 12 healthy volunteers
was radioprotective not only at 0 h, but also at 90 min post irradiation (Tables 1 - 2, Fig. 1 -
2). Furthermore, after 2 Gy irradiation of PBL (Table 5), the resulting regression equation is:
Y = 198.23 + (-0.06)D, where Y is the MN yield per 1000 BN cells and D is the NAGE
concentration. Therefore, this model suggests theoretically that at 90 min after a 2 Gy
irradiation, the application of the lowest NAGE concentration (50 ug ml-1) induced a reduction
of MN yield from 198.23 to 195.23, with a reduction of 3 MN per 1000 BN cells; and the
application of the highest NAGE concentration (1000 ug ml-1) induced a reduction of MN yield
from 198.23 to 138.23, with a reduction of 60 MN per 1000 BN cells. The observed extended
NAGE radioprotection time of 90 min post irradiation in PBL indicates a longer window of
protection against IR exposure ex vivo. We believe this new finding may be particularly
important for the triage management of IR-exposed victims.
The radioprotective effect of NAGE on MN yield in human PBL is further supported by two
additional MN-related parameters: MN+BN index, and the number of MN per BN cell. Because
MN+BN index is the percentage of the total number of BN cells with a varying number of MN
in the cytoplasm, it indicates the spectrum of DNA damage in BN cells (Lee et al., 2004a; Lee
et al., 2005). Because a direct correlation exists between MN yield and genomic damage
(Fenech, 2005), the number of MN per BN cell is a reflection of the degree of IR-induced DNA
damage within a cell. We found that in the irradiated PBL population, increasing concentrations
of NAGE in the culture medium resulted in a decrease in both MN+BN index and number of
BN lymphocytes containing ≥ 2 MN (Table 3-4), implying the efficacy of NAGE in reducing
IR-induced DNA damage. Furthermore, the radioprotection of NAGE occurred without
apparent genomic toxicity, based on the fact that incubation with PBL at a concentration up to
1000 μg ml-1 caused no increase in MN yield (Tables 1 -2).
Amifostine (WR-2720), the most comprehensively studied radioprotector, is the only
radioprotective drug that is FDA-approved for the prevention of xerostomia in head and neck
cancer patients undergoing radiotherapy. Because MN induction in PBL is an accurate
parameter for measuring the radioprotective potential of aminothiols (Littlefield et al., 1993),
we used it as the end point in comparing the radioprotective efficacy of NAGE with that of the
synthetic aminothiol WR-1065, the active metabolite of amifostine. MN reduction is the ratio
of relative reduction of MN yield in PBL incubated with different concentrations of NAGE or
WR-1065, compared to MN yield with radiation alone. We found that at 0 h (Table 1) after 1
Gy irradiation, the maximum MN reduction caused by NAGE and WR-1065 was 49.2% and
LEE et al. Page 6
Phytother Res. Author manuscript; available in PMC 2009 February 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
61.2%, respectively; after 2 Gy irradiation, it was 48.8% and 54.4%, respectively. At 90 min
post irradiation (Table 2) of 1 Gy, the maximum MN reduction caused by NAGE and WR-1065
was 53.8% and 59.2%, respectively; after 2 Gy irradiation, it was 37.3% and 42%, respectively.
Our results indicate that the radioprotective potential of NAGE against 137 Cs-induced MN
formation in PBL is comparable with that of WR-1065.
Since the proliferative index (PI) in culture cells reflects cell cycle kinetics, we further
determined the PI in PBL before and after 137Cs exposure to determine whether different
concentrations of NAGE (50 - 1000 μgml-1) and WR-1065 (1 or 3 mM), or their metabolites
might stimulate or inhibit mitosis. We found that PI was not altered significantly in the presence
of NAGE or WR-1065 at different time points (data not shown), suggesting that neither before
nor after irradiation did NAGE or WR-1065 alter subsequent cell cycle progression or the
ability of PBL to respond to PHA stimulation. These results are in agreement with those
reported in the literature (Lee et al., 2004a; Littlefield et al., 1993). Further, we found that the
intercellular distribution of MN in PBL follows a non-Poisson distribution in all cases.
It is known that IR induces DNA damage in mammalian cells predominantly by direct
ionization and through generation of hydroxyl radicals that attack cellular DNA. After radiation
exposure, WR-1065 and other non-protein thiols provide cytoprotection by their ability to
scavenge highly reactive free radicals formed by oxidative stress (Littlefield et al 1993; Weiss
and Landauer, 2003). Antioxidants may interfere with the initial apoptosis induced by IR
exposure (Weiss and Landauer, 2003). Antioxidants may interfere with the initial apoptosis
induced by IR exposure (Weiss and Landauer, 2003). The antioxidative and free radical
scavenging effects of Asian ginseng have been well documented (Attele et al., 1999; Han et
al., 2005; Kumar et al., 2003; Kitts et al., 2000; Lee et al., 2005; Lee et al., 2006). The cell
membranes of PBL have a very high phospholipid content, rendering them vulnerable to
oxidative damage (Block and Mead, 2003); however, the exact radioprotective mechanism of
the standardized NAGE on human PBL is unclear (Lee et al., 2005). The radioprotective effect
of NAGE on human PBL, like that of WR-1065, is probably related to its scavenging of
radiation-induced free radicals, based on the following evidence: (1) ginsenosides function as
antioxidants that protect the outer membrane of mammalian cells (Block and Mead, 2003); (2)
NAGE inhibits lipid peroxidation through transition metal chelation and scavenging of
hydroxyl and superoxide radicals (Kitts et al., 2000; Lee et al., 2005); (3) ginsenoside Rb1
inhibits peroxyl radical-induced DNA breakage (Kang et al., 2007; Kitts et al., 2000); (4)
NAGE has a markedly higher ginsenoside Rb1/Rb2 ratio than Panax ginseng (Kitts et al.,
2000), and (5) the total ginsenoside concentration (w/w) of the standardized NAGE we applied
in this study is 11.7%, which is much higher than the 4% total ginsenoside concentration that
usually appears in the literature (Hall et al., 2001).
Taken together, the results generated from this study strongly support our hypothesis that
standardized NAGE protects human PBL ex vivo against IR-induced DNA damage, as
evidenced by a NAGE dose-dependent reduction in the 137Cs-induced MN yield. Under similar
experimental conditions, the radioprotective effect of NAGE is comparable with that of
WR-1065. The novelty of the present report lies in our finding that this NAGE radioprotection
extends from 0 h to 90 minutes after radiation exposure. This long window of protection could
have major implications for clinical radiotherapy and for victims of accidental or deliberate
radiation exposure. Compared with WR-1065, NAGE is a low-cost and relatively non-toxic
natural product with numerous medicinal properties that can be administered easily as a dietary
supplement. Therefore, we believe NAGE to be an excellent candidate for further trials. Our
subsequent studies will investigate the possible mechanisms underlying the radioprotection
conferred by NAGE, including how NAGE modulates the redox homeostasis in human PBL.
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Figure 1.
Effect of NAGE (μg ml-1) applied at 0 h (A) and 90 min after radiation exposure (B)
on 137Cs-induced MN yields in binucleated (BN) lymphocytes, compared to their respective
irradiated controls (*P<0.005, **P<0.001). Each bar represents the mean ± SEM of two
independent determinations pooled from 12 individuals.
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Fig.2.
Effect of WR-1065 (mM) applied at 0 h (A) and 90 min after radiation exposure (B) on 137Cs-
induced MN yields in binucleated (BN) lymphocytes, compared to their respective irradiated
controls (*P<0.005, **P<0.001). Each bar represents the mean ± SEM of two independent
determinations pooled from 12 individuals.
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